270 likes | 459 Views
Practice Alert Dysrhythmia Monitoring. Issued April 2008. Authors & Reviewers: Nancy M. Richards, RN, CNS, MSN, CCRN, CCNS. Lecture Content. Skin Preparation Lead Placement Ventricular Dysrhythmias QT Intervals. Skin Preparation. Skin oil and debris can cause noisy signals
E N D
Practice AlertDysrhythmia Monitoring Issued April 2008 Authors & Reviewers: Nancy M. Richards, RN, CNS, MSN, CCRN, CCNS
Lecture Content • Skin Preparation • Lead Placement • Ventricular Dysrhythmias • QT Intervals Practice Alert - Dysrhythmia Monitoring
Skin Preparation • Skin oil and debris can cause noisy signals • Clip excessive hair before placing electrodes • Clean skin with alcohol or washcloth to remove skin oils and/or debris Practice Alert - Dysrhythmia Monitoring
Electrode Placement • Limb leads (I,II,III) • Place to decrease muscle artifact during limb movement • Placement • Right Arm (RA) infra-clavicular fossa close to right shoulder • Left Arm (LA) infra-clavicular fossa close to left shoulder • Left Leg (LL) below rib cage on left side of abdomen • Ground (RL) anywhere on torso Practice Alert - Dysrhythmia Monitoring
Electrode Placement • Precordial Leads • Dependent on patient’s needs and goals of monitoring • Consider marking electrode location with indelible ink • Ensures electrodes will be placed in same position. • Precordial leads misplaced by 1 ICS can change the QRS morphology Practice Alert - Dysrhythmia Monitoring
Dysrhythmia Monitoring • Lead V1 to distinguish Ventricular Tachycardia (VT) from Supraventricular Tachycardia (SVT) with aberrant conduction • V1 lead of choice for dysrhythmia monitoring • Lead II or III if patient condition indicates need to monitor for atrial dysrhythmias Practice Alert - Dysrhythmia Monitoring
Dysrhythmia Monitoring Lead Placement • V1 (5 lead system) • 4th intercostal space (ICS) to the right of the sternum • MCL1(3 lead system) • 4th intercostal space (ICS) to the right of the sternum Practice Alert - Dysrhythmia Monitoring
3 Lead Electrode Placement • Simple 3-electrode lead system • Electrode placement for MCL1 • Only 1 lead can be monitored with a 3 lead system Practice Alert - Dysrhythmia Monitoring From Philips Cardiac Monitoring Pocket Card 2002
Angle of Louis 5 Lead Electrode Placement 5 lead systems allow for the recording of any of the six limb leads plus one precordial (V) lead. Shown lead placement for recording V1 or V6. 5 Lead monitoring systems are recommended over 3 lead systems for monitoring QRS morphology V1 V6 Practice Alert - Dysrhythmia Monitoring From Philips Cardiac Monitoring Pocket Card 2002
V 1 or MCL1 Monophasic R wave Notched R wave with taller left peak Biphasic RS Biphasic qR Any of the following in V1 or V2 R > 30ms Slurred or notched S descent QRS onset to S nadir >60 ms V6 or MCL6 Biphasic rS with R:S ratio <1.0 Monophasic Q Notched QS Biphasic qR Intrinsicoid deflection > 70ms QRS Morphology Ventricular Tachycardia Practice Alert - Dysrhythmia Monitoring
QRS Morphology From Philips Cardiac Monitoring Pocket Card 2002 Practice Alert - Dysrhythmia Monitoring
V1 or MCL1 Bimodal rR’ or triphasic rsR’ All of the following in V1 or V2 R < 30 ms or no R Straight S descent QRS onset to S nadir < 60 ms and no Q in V6 V6 or MCL6 Triphasic qRs with R:s ratio > 1.0 Intrinsicoid deflection < 50 ms QRS MorphologySVT with Aberration Practice Alert - Dysrhythmia Monitoring
QRS Morphology Practice Alert - Dysrhythmia Monitoring From Philips Cardiac Monitoring Pocket Card 2002
V1 or MCL1 R slurred or notched with taller right peak V6 or MCL6 Monophasic R Notched R with taller left or right peak Biphasic Rs with R:S ratio > 1.0 QRS Morphology Not Helpful Applies only to tachycardias with a positive waveform in V1 Practice Alert - Dysrhythmia Monitoring
QRS Morphology Practice Alert - Dysrhythmia Monitoring From Philips Cardiac Monitoring Pocket Card 2002
V1 II V1 II Accurate Lead Placement (B) After lead placement was corrected, another episode of wide QRS complex tachycardia showed the “taller left peak” pattern in lead V1 which is strongly suggestive of ventricular tachycardia (Wellens, et al 1978). Subsequent invasive cardiac electrophysiologic study confirmed the patient had ventricular tachycardia. (A) Onset of wide QRS complex tachycardia shows a “taller right peak” pattern in lead V1, which is unhelpful in distinguishing between ventricular tachycardia and supraventricular tachycardia with aberrant conduction. Examination of the patient revealed that the V1 electrode was misplaced to the 5th, rather than the 4th intercostal space Practice Alert - Dysrhythmia Monitoring Used with permission of Barbara J. Drew RN, PhD
QT Interval • Approximate measure of the duration of ventricular repolarization. • Measured from the beginning of the Q wave to the end of the T wave • Varies with heart rate • Lengthens with bradycardia • Shortens with tachycardia Practice Alert - Dysrhythmia Monitoring
QT Interval Measure from beginning of the QRS complex to the end of the T wave Practice Alert - Dysrhythmia Monitoring From Philips Cardiac Monitoring Pocket Card 2002
QTc Interval • QT interval corrected for heart rate (QTc) • Formula for calculating QTc (Bazett’s formula) • QTc > 0.50 seconds considered dangerously prolonged and is associated with a higher risk of Torsades de Pointes. Practice Alert - Dysrhythmia Monitoring
R – R = 0.72 QT = 0.36 Measuring the QTc • Measure the QT of the second complex used in R – R measurement. • Using Bazett’s formula: QTc = 0.36 / √0.72 = 0.36 / 0.85 = 0.42 • QTc = 0.42 Practice Alert - Dysrhythmia Monitoring
Torsades de Pointes • Polymorphic Ventricular Tachycardia • Precipitated by prolonged QT interval • Not responsive to and may be exacerbated by class Ia and some Ic medications Practice Alert - Dysrhythmia Monitoring
Pause Arrhythmias associated with prolonged QT interval that place the patient at immediate risk for developing torsades de pointes. ECG characteristics include underlying prolonged QT interval, T wave alternans, polymorphic ventricular premature beats that fall near the T-U portion of repolarization, pause-dependent enhancement of the QT interval (arrow), and non-sustained polymorphic ventricular tachycardia. Used with permission of Barbara J. Drew RN, PhD Practice Alert - Dysrhythmia Monitoring
Torsades de Pointes • Monitor QT interval for patients identified at high risk: • Patients on medications known to prolong QT interval • Quinidine, procainaminde, disopyraminde, sotalol, dofetilide, ibutilide • For more information see: http://www.arizonacert.org/medical-pros/drug-lists/printable-drug-list.cfm • Patients who overdose on potentially pro- dysrhythmic medications • New onset bradycardia • Severe hypokalemia or hypomagnesemia Practice Alert - Dysrhythmia Monitoring
Treatment • Emergency • IV Magnesium • Defibrillation • Overdrive • pacing • Long Term • Monitor QTc • interval • Discontinue or • modify drug dose • if QTc interval • increases > 0.50 • secs Practice Alert - Dysrhythmia Monitoring
Need Further Assistance? • For more information or further assistance, please contact a clinical practice specialist with the AACN Practice Resource Network. Email: practice@aacn.org Phone: (800) 394-5995 Practice Alert - Dysrhythmia Monitoring